OBIO Earnings

Quarterly EPS
$-0.41
Q3 2024
$-0.42
Q4 2024
$-0.49
Q1 2025
$-0.50
Q2 2025
$-0.40
Q3 2025
$0.10
Q4 2025
$-0.33
Q1 2026
$-0.38
Q2 2026
Latest Revenue88.0K
Latest Net Income-23755000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.3888.0K-23755000-89.5%+24.0%
Q1 2026-$0.33110.0K-20691000-87.3%+32.7%
Q4 2025$0.1030.9M6.2M+12,120.2%+123.8%
Q3 2025-$0.40861.0K-20828000-12.8%+2.4%
Q2 2025-$0.50836.0K-19363000+7.5%-11.1%
Q1 2025-$0.49868.0K-18755000+40.0%-28.9%
Q4 2024-$0.42253.0K-16155000-3.4%-16.7%
Q3 2024-$0.41987.0K-15426000+135.6%-7.9%
Q2 2024-$0.45778.0K-15980000
Q1 2024-$0.38620.0K-13463000
Q4 2023-$0.36262.0K-12818000
Q3 2023-$0.38419.0K-13316000
Orchestra BioMed (OBIO) — Earnings